She is a Physician/Immunologist and Associate Professor of Medicine in the Department of Gastroenterology at Tongji Hospital, HUST, where she received her MD degree in 2002, followed by a doctoral degree in Immunology in 2006 at Queen’s University of Belfast, Northern Ireland. Dr. Chen had post-doctoral research training for 5 years at the NIAID, NIH, including her work on HIV/AIDS at the Ragon Institute of MGH, MIT and Harvard. She has received considerable funding from the National Nature Science Foundation of China to study the role of hepatic stellate cells (HSC) in cirrhosis and its associated T regulatory induction. Dr. Chen’s work also includes studies on genetics and epigenetics of liver cancer, and the inflammation of GI tract, with a particular interest in the field of immunogenetics and the effect of immune modulation of chronic infections on hepatitis and cirrhosis. Her current projects include studying S. japonicum infection among larger numbers of patient samples to understand the molecular biology and genetic mechanisms, of which contribute to the human immune response of individuals who are resistant to the parasite infection.
Immunology in GI; Molecular Biology in Cancer; Epigenetic;